Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016 (2016), Article ID 3507290, 10 pages
http://dx.doi.org/10.1155/2016/3507290
Research Article

Inhibition of HSP90 Promotes Neural Stem Cell Survival from Oxidative Stress through Attenuating NF-κB/p65 Activation

1Department of Neurology, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, Jiangsu 210002, China
2School of Dentistry, Cardiff Institute of Tissue Engineering and Repair, Cardiff University, Heath Park, Cardiff CF14 4XY, UK
3State Key Laboratory of Military Stomatology & National Clinical Research Centre for Oral Diseases & Shaanxi Key Laboratory of Oral Diseases, Department of Operative Dentistry & Endodontics, School of Stomatology, Fourth Military Medical University, No. 145 Western Changle Road, Xi’an, Shaanxi 710032, China
4Department of Chemistry & Chemical Biology, MSC03 2060, University of New Mexico, Clark Hall B58, Albuquerque, NM 87131-0001, USA
5College of Chemistry and Materials Science, Jiangsu Key Laboratory of Biofunctional Materials, Nanjing Normal University, Nanjing 210023, China

Received 8 June 2016; Revised 23 August 2016; Accepted 25 August 2016

Academic Editor: Javier Egea

Copyright © 2016 Qian Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. H. Gage and S. Temple, “Neural stem cells: generating and regenerating the brain,” Neuron, vol. 80, no. 3, pp. 588–601, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Martino and S. Pluchino, “The therapeutic potential of neural stem cells,” Nature Reviews Neuroscience, vol. 7, no. 5, pp. 395–406, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. B. A. Reynolds and S. Weiss, “Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system,” Science, vol. 255, no. 5052, pp. 1707–1710, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. Q. Wang, F. Duan, M.-X. Wang, X.-D. Wang, P. Liu, and L.-Z. Ma, “Effect of stem cell-based therapy for ischemic stroke treatment: a meta-analysis,” Clinical Neurology and Neurosurgery, vol. 146, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  5. M. Chomova and I. Zitnanova, “Look into brain energy crisis and membrane pathophysiology in ischemia and reperfusion,” Stress, vol. 19, no. 4, pp. 341–348, 2016. View at Publisher · View at Google Scholar
  6. P. M. Guedes, C. M. Andrade, D. F. Nunes et al., “Inflammation enhances the risks of stroke and death in chronic chagas disease patients,” PLoS Neglected Tropical Diseases, vol. 10, no. 4, Article ID e0004669, 2016. View at Publisher · View at Google Scholar
  7. D. M. Hermann, L. Peruzzotti-Jametti, J. Schlechter, J. D. Bernstock, T. R. Doeppner, and S. Pluchino, “Neural precursor cells in the ischemic brain—integration, cellular crosstalk, and consequences for stroke recovery,” Frontiers in Cellular Neuroscience, vol. 8, article 291, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Kong, J. Zhu, Q. Liu et al., “Mesenchymal stem cells protect neurons against hypoxic-ischemic injury via inhibiting parthanatos, necroptosis, and apoptosis, but not autophagy,” Cellular and Molecular Neurobiology, 2016. View at Publisher · View at Google Scholar
  9. R. Khatri, S. Krishnan, S. Roy, S. Chattopadhyay, V. Kumar, and A. Mukhopadhyay, “Reactive oxygen species limit the ability of bone marrow stromal cells to support hematopoietic reconstitution in aging mice,” Stem Cells and Development, vol. 25, no. 12, pp. 948–958, 2016. View at Publisher · View at Google Scholar
  10. Q. Liu, J.-P. Kou, and B.-Y. Yu, “Ginsenoside Rg1 protects against hydrogen peroxide-induced cell death in PC12 cells via inhibiting NF-κB activation,” Neurochemistry International, vol. 58, no. 1, pp. 119–125, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. Q. Liu, X. Fan, J. Zhu, G. Xu, Y. Li, and X. Liu, “Co-culturing improves the OGD-injured neuron repairing and NSCs differentiation via Notch pathway activation,” Neuroscience Letters, vol. 559, pp. 1–6, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Kumar, G. Negi, and S. S. Sharma, “JSH-23 targets nuclear factor-kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence,” Diabetes, Obesity and Metabolism, vol. 13, no. 8, pp. 750–758, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Guan, Q. Liu, Y. Qian et al., “Ruscogenin reduces cerebral ischemic injury via NF-κB-mediated inflammatory pathway in the mouse model of experimental stroke,” European Journal of Pharmacology, vol. 714, no. 1–3, pp. 303–311, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. J. E. Lee, M. S. Lim, J. H. Park, C. H. Park, and H. C. Koh, “Nuclear NF-κB contributes to chlorpyrifos-induced apoptosis through p53 signaling in human neural precursor cells,” NeuroToxicology, vol. 42, pp. 58–70, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Qian, L. Cao, T. Guan et al., “Protection by genistein on cortical neurons against oxidative stress injury via inhibition of NF-kappaB, JNK and ERK signaling pathway,” Pharmaceutical Biology, vol. 53, no. 8, pp. 1124–1132, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. L. H. Pearl, “Review: the HSP90 molecular chaperone—an enigmatic ATPase,” Biopolymers, vol. 105, no. 8, pp. 594–607, 2016. View at Publisher · View at Google Scholar
  17. A. Haque, Q. Alam, M. Z. Alam et al., “Current understanding of HSP90 as a novel therapeutic target: an emerging approach for the treatment of cancer,” Current Pharmaceutical Design, vol. 22, no. 20, pp. 2947–2959, 2016. View at Publisher · View at Google Scholar
  18. M. R. DeFee, Z. Qin, L. Dai, B. P. Toole, J. S. Isaacs, and C. H. Parsons, “Extracellular Hsp90 serves as a co-factor for NF-κB activation and cellular pathogenesis induced by an oncogenic herpesvirus,” American Journal of Cancer Research, vol. 1, no. 5, pp. 687–700, 2011. View at Google Scholar
  19. M. Broemer, D. Krappmann, and C. Scheidereit, “Requirement of Hsp90 activity for IκB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-κB activation,” Oncogene, vol. 23, no. 31, pp. 5378–5386, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Tago, F. Tsukahara, M. Naruse, T. Yoshioka, and K. Takano, “Hsp90 inhibitors attenuate effect of dexamethasone on activated NF-κB and AP-1,” Life Sciences, vol. 74, no. 16, pp. 1981–1992, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. Z. Solarova, J. Mojzis, and P. Solar, “Hsp90 inhibitor as a sensitizer of cancer cells to different therapies (review),” International Journal of Oncology, vol. 46, no. 3, pp. 907–926, 2015. View at Publisher · View at Google Scholar